Prediction of virologic response to tenofovir mono-rescue therapy for multidrug resistant chronic hepatitis B-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Prediction of virologic response to tenofovir mono-rescue therapy for multidrug resistant chronic hepatitis B

Published:2015-11-19 Issue:6 Volume:88 Page:1027-1034
ISSN:0146-6615
Container-title:Journal of Medical Virology
language:en
Short-container-title:J. Med. Virol.

Author:

Lee Sangheun¹²³⁴,Park Jun Yong¹²,Kim Do Young¹²,Kim Beom Kyung¹²,Kim Seung Up¹²,Song Kijun⁵,Ku Hye Jin¹,Han Kwang-Hyub¹²,Ahn Sang Hoon¹²

Affiliation:

1. Department of Internal Medicine; Yonsei University College of Medicine; Seoul Republic of Korea

2. Institute of Gastroenterology; Yonsei University College of Medicine; Seoul Republic of Korea

3. Department of Internal Medicine; Catholic Kwandong University College of medicine; International St. Mary's Hospital; Incheon Republic of Korea

4. Institute for Integrative Medicine; Catholic Kwandong University College of medicine; International St. Mary's Hospital; Incheon Republic of Korea

5. Department of Biostatistics; Yonsei University College of Medicine; Seoul Korea

Publisher

Wiley

Subject

Infectious Diseases,Virology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1002/jmv.24427/fullpdf

Reference36 articles.

1. Telbivudine in combination with adefovir versus adefovir monotherapy in HBeAg-positive, lamivudine-resistant chronic hepatitis B;Ahn;Hepatol Int,2012

2. Tenofovir is effective alone or with emtricitabine in adefovir-treated patients with chronic-hepatitis B virus infection;Berg;Gastroenterology,2010

3. Performance of transient elastography for the staging of liver fibrosis in patients with chronic hepatitis B: A meta-analysis;Chon;PLoS ONE,2012

4. EASL clinical practice guidelines: Management of chronic hepatitis B virus infection;J Hepatol,2012

5. Randomized comparison of tenofovir disoproxil fumarate vs emtricitabine and tenofovir disoproxil fumarate in patients with lamivudine-resistant chronic hepatitis B;Fung;Gastroenterology,2014

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Treatment Outcome and Renal Safety of 3-Year Tenofovir Disoproxil Fumarate Therapy in Chronic Hepatitis B Patients with Preserved Glomerular Filtration Rate;Gut and Liver;2019-01-15

2. Efficacy of tenofovir disoproxil fumarate switch therapy in chronic hepatitis B patients with suboptimal response to adefovir‑based combination therapy;Experimental and Therapeutic Medicine;2018-12-11

3. Step-down strategy in antiviral resistant chronic hepatitis B patients who achieved viral suppression with rescue combination therapy;Future Virology;2018-10-01

4. Real World Experience of Telbivudine Versus Entecavir in Patients with Chronic Hepatitis B, Including Long-Term Outcomes after Treatment Modification;Yonsei Medical Journal;2018

5. The Effect of Naïve Tenofovir Dipivoxil Fumarate Monotherapy in Patients with Chronic Hepatitis B: 2-Year Results of a Real-world Single-center Study;The Korean Journal of Medicine;2017-04-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3